About SurgBoardsQ&A

Built by surgeons, for surgeons.

Why this exists

This platform was not born in a product meeting. It was born in the gap between what surgical candidates need and what currently exists.

A resident preparing for FEBS-SO should not be using the same unfiltered question bank as someone sitting ABSITE. The content requirements are different. The exam format is different. The guideline corpus is different. Yet every platform on the market treats all surgical boards as a single undifferentiated blob.

No single resource covers both US and European certification pathways. Candidates preparing for FEBS specialty boards — HPB, Colorectal, Endocrine, Esophago-Gastric — have essentially no board-specific question bank to practice with. They compile their own materials from textbooks, guideline PDFs, and journal articles, and hope for the best.

SurgBoardsQ&A addresses all of this: board-specific question sets, explanations referenced to current guidelines (ESMO, NCCN, PSOGI, JGCA), automatic weak-area detection, and a single platform that grows as new boards are added.

What makes it different

Board-mapped content

Every question is tagged to a specific board and its official syllabus. Filter by FEBS-SO, ABS-CGSO, ABSITE, or any specialty FEBS exam.

Current guidelines

Explanations cite ESMO, NCCN, PSOGI, and JGCA where applicable. When guidelines change, the explanations change.

Written by a specialist

Questions and explanations are authored by a surgical oncologist with subspecialty expertise in peritoneal malignancy and sarcoma.

Author

Author

Pablo Lozano Lominchar, MD, PhD, EBPSM

Surgical Oncologist · Surgical Oncology

Malignant Peritoneal Disease, Sarcoma and Complex Pelvic Surgery

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Associate Professor of Surgery — Universidad Complutense de Madrid

Sarcoma and Mesenchymal Tumors Section — Asociación Española de Cirujanos (AEC)

ORCID: 0000-0002-5413-8449

Platform created in personal capacity as educator. Does not represent Hospital Gregorio Marañón or UCM.

Platform principles

  • 1Every explanation references a specific guideline, landmark trial, or consensus statement — no opinion-based answers.
  • 2Free tier is genuinely free: 25 questions per day, no credit card, no dark patterns.
  • 3No pharmaceutical sponsorship. No advertising. Revenue comes from subscriptions only.
  • 4Content is updated when guidelines change, not on an annual cycle.
  • 5Covers both US (ABS) and European (FEBS, FRCS) certification pathways — no other platform does.

External profiles